IOTA BIOSCIENCES
IOTA BIOSCIENCES
Social Links:
Industry:
Biotechnology
Founded:
2017-01-01
Address:
Berkeley, California, United States
Country:
United States
Website Url:
http://www.iota.bio
Total Employee:
11+
Status:
Active
Total Funding:
15 M USD
Technology used in webpage:
Microsoft Azure DNS Mimecast
Similar Organizations
Themis Bioscience
Themis Bioscience is a start-up biotechnology company.
Current Advisors List
Current Employees Featured
Founder
Investors List
Ironfire Ventures
Ironfire Ventures investment in Series A - Iota Biosciences
Berkeley SkyDeck Fund
Berkeley SkyDeck Fund investment in Series A - Iota Biosciences
Horizons Ventures
Horizons Ventures investment in Series A - Iota Biosciences
Astellas Pharma
Astellas Pharma investment in Series A - Iota Biosciences
Shanda Group
Shanda Group investment in Series A - Iota Biosciences
Bold Capital Partners
Bold Capital Partners investment in Series A - Iota Biosciences
The House Fund
The House Fund investment in Series A - Iota Biosciences
Official Site Inspections
http://www.iota.bio
- Host name: 40.71.11.163
- IP address: 40.71.11.163
- Location: Washington United States
- Latitude: 38.7095
- Longitude: -78.1539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 22747
More informations about "Iota Biosciences" on Search Engine
Astellas Completes Acquisition of iota Biosciences
Oct 30, 2020 acquisition of Iota Biosciences, Inc. (“iota”), a start-up company focused on the bioelectronics field, located in Berkeley, California, and iota has become a wholly …See details»
Iota Biosciences - Crunchbase Company Profile & Funding
Iota Biosciences develops a platform to empower the future of bioelectronic medicine. The company's ultra-compact, low-power gadgets aid in utilizing the human nervous …See details»
Astellas to Acquire iota Biosciences
Oct 15, 2020 Established in 2017, iota Biosciences was formed with a vision to change how the world monitors and treats disease. Building on award-winning 'neural-dust' …See details»
News | Astellas Pharma Inc.
TOKYO October 30, 2020 - Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas”) announced today that it has completed the acquisition of …See details»
iota Biosciences, Inc. powered by Astellas | LinkedIn
Iota Biosciences, a wholly-owned subsidiary of Astellas Pharma US, is a medical device company pioneering bioelectronic solutions across a range of medical therapies and diagnostics.See details»
Iota Biosciences - Funding, Financials, Valuation
Iota Biosciences is funded by 7 investors. Ironfire Ventures and Berkeley SkyDeck Fund are the most recent investors. Which investors participated in the most funding rounds?See details»
iota Biosciences, Inc. powered by Astellas | The Org
Iota Biosciences, a wholly-owned subsidiary of Astellas Pharma US, is a medical device company pioneering bioelectronic solutions across a range of medical therapies and …See details»
Iota Biosciences - Contacts, Employees, Board …
Iota Biosciences has 2 current employee profiles, including Founder and Co-CEO Michel Maharbiz. Iota Biosciences has 1 board member or advisor, Konstantinos Alataris.See details»
Iota Biosciences Company Profile - Craft
Iota Biosciences engages in the development of implantable millimeter-wide sensors that can live in a human body and transmit wirelessly what they detect. The Company's …See details»
Gentle Single-Cell Isolation and Handling Solutions - Iota Sciences
IotaSciences offers efficient automation for gentle single-cell isolation and single-cell cloning, as well as expert cell-line engineering services focussed on human induced …See details»
Astellas Completes Acquisition of iota Biosciences
On October 30, 2020 Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") reported that it has completed the acquisition of Iota …See details»
Iota Biosciences Company Profile 2024: Valuation, Investors ...
Information on acquisition, funding, cap tables, investors, and executives for Iota Biosciences. Use the PitchBook Platform to explore the full profile.See details»
Astellas to Acquire iota Biosciences | Business Wire
Oct 15, 2020 Under the Merger Agreement, Astellas will make an initial payment of approximately US$127.5 million to acquire all of the outstanding equity in iota not already …See details»
Astellas and iota Biosciences Enter into Collaborative Research …
Sep 13, 2019 Established in 2017, iota Biosciences was formed with a vision to change how the world monitors and treats disease. Building on award-winning 'neural-dust' …See details»
iota Biosciences - Technical Program Manager
Iota Biosciences, a wholly-owned subsidiary of Astellas Pharma US, is a medical device company pioneering bioelectronic solutions across a range of medical therapies and …See details»
Astellas to Acquire iota Biosciences | Nasdaq
Oct 15, 2020 Through the acquisition of iota, Astellas will acquire iota’s unique bioelectronics technology and world-class talent. This acquisition, which contemplates …See details»
Iota Biosciences - Tech Stack, Apps, Patents & Trademarks
Organization. Iota Biosciences. Connect to CRM. Summary Financials People Technology Signals & News Similar Companies. Highlights. Active Tech Count 20. Monthly Visits …See details»
iota Biosciences - Staff Design Verification Engineer
We are looking for a Staff Design Verification Engineer who will leverage their advanced wide-ranging experience in development of active implantable medical devices to …See details»